JP2019534329A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534329A5 JP2019534329A5 JP2019545865A JP2019545865A JP2019534329A5 JP 2019534329 A5 JP2019534329 A5 JP 2019534329A5 JP 2019545865 A JP2019545865 A JP 2019545865A JP 2019545865 A JP2019545865 A JP 2019545865A JP 2019534329 A5 JP2019534329 A5 JP 2019534329A5
- Authority
- JP
- Japan
- Prior art keywords
- dietary supplement
- pharmaceutical composition
- fatty acid
- composition
- supplement composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 24
- 235000015872 dietary supplement Nutrition 0.000 claims 21
- 239000008194 pharmaceutical composition Substances 0.000 claims 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 17
- 239000003795 chemical substances by application Substances 0.000 claims 11
- 230000002209 hydrophobic effect Effects 0.000 claims 11
- 235000021466 carotenoid Nutrition 0.000 claims 10
- 150000001747 carotenoids Chemical class 0.000 claims 10
- 208000035475 disorder Diseases 0.000 claims 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims 7
- 229930195729 fatty acid Natural products 0.000 claims 7
- 239000000194 fatty acid Substances 0.000 claims 7
- 150000004665 fatty acids Chemical class 0.000 claims 7
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims 6
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims 6
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 6
- 150000004671 saturated fatty acids Chemical class 0.000 claims 6
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims 5
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims 5
- 210000004185 liver Anatomy 0.000 claims 5
- 235000012661 lycopene Nutrition 0.000 claims 5
- 239000001751 lycopene Substances 0.000 claims 5
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims 5
- 229960004999 lycopene Drugs 0.000 claims 5
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims 5
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims 5
- 235000012000 cholesterol Nutrition 0.000 claims 4
- 206010021143 Hypoxia Diseases 0.000 claims 3
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims 3
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims 3
- 230000007954 hypoxia Effects 0.000 claims 3
- 235000012680 lutein Nutrition 0.000 claims 3
- 239000001656 lutein Substances 0.000 claims 3
- 229960005375 lutein Drugs 0.000 claims 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims 3
- 235000020674 meso-zeaxanthin Nutrition 0.000 claims 3
- 230000036542 oxidative stress Effects 0.000 claims 3
- 230000008685 targeting Effects 0.000 claims 3
- 150000003626 triacylglycerols Chemical class 0.000 claims 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims 3
- 235000010930 zeaxanthin Nutrition 0.000 claims 3
- 239000001775 zeaxanthin Substances 0.000 claims 3
- 229940043269 zeaxanthin Drugs 0.000 claims 3
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 235000013793 astaxanthin Nutrition 0.000 claims 2
- 239000001168 astaxanthin Substances 0.000 claims 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims 2
- 229940022405 astaxanthin Drugs 0.000 claims 2
- 229940110456 cocoa butter Drugs 0.000 claims 2
- 235000019868 cocoa butter Nutrition 0.000 claims 2
- 230000035487 diastolic blood pressure Effects 0.000 claims 2
- 235000004626 essential fatty acids Nutrition 0.000 claims 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims 2
- 230000004792 oxidative damage Effects 0.000 claims 2
- 235000003441 saturated fatty acids Nutrition 0.000 claims 2
- 230000035488 systolic blood pressure Effects 0.000 claims 2
- 201000004569 Blindness Diseases 0.000 claims 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 235000019486 Sunflower oil Nutrition 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
- 230000006749 inflammatory damage Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000008798 inflammatory stress Effects 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 150000004668 long chain fatty acids Chemical class 0.000 claims 1
- 210000004324 lymphatic system Anatomy 0.000 claims 1
- 150000004667 medium chain fatty acids Chemical class 0.000 claims 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 1
- 150000002978 peroxides Chemical class 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 1
- 235000013824 polyphenols Nutrition 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 235000021391 short chain fatty acids Nutrition 0.000 claims 1
- 150000004666 short chain fatty acids Chemical class 0.000 claims 1
- 239000002600 sunflower oil Substances 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 230000004393 visual impairment Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL419363A PL419363A1 (pl) | 2016-11-04 | 2016-11-04 | Inteligentne dostarczanie przyjmowanych i wchłanianych cząsteczek |
| PLP.419363 | 2016-11-04 | ||
| GB201618733 | 2016-11-07 | ||
| GB1618733.8 | 2016-11-07 | ||
| GB1705491.7 | 2017-04-05 | ||
| GBGB1705491.7A GB201705491D0 (en) | 2017-04-05 | 2017-04-05 | Intelligent delivery of ingested and absorbed molecules |
| PCT/EP2017/078242 WO2018083271A1 (en) | 2016-11-04 | 2017-11-03 | Inteligent delivery of ingested and absorbed molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019534329A JP2019534329A (ja) | 2019-11-28 |
| JP2019534329A5 true JP2019534329A5 (enExample) | 2020-12-17 |
Family
ID=60382179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545865A Pending JP2019534329A (ja) | 2016-11-04 | 2017-11-03 | 摂取および吸収された分子の知的送達 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11696920B2 (enExample) |
| EP (1) | EP3534884A1 (enExample) |
| JP (1) | JP2019534329A (enExample) |
| CN (1) | CN110198706A (enExample) |
| BR (1) | BR112019008739A2 (enExample) |
| CA (1) | CA3042592A1 (enExample) |
| IL (1) | IL266385A (enExample) |
| WO (1) | WO2018083271A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12094109B2 (en) * | 2018-10-19 | 2024-09-17 | Takeda Pharmaceutical Company Limited | Image scoring for intestinal pathology |
| MX2022001238A (es) * | 2019-08-13 | 2022-07-13 | Team Foods Colombia Sa | Composicion lipidica que comprende antioxidantes y polifenoles naturales como alternativa no farmacologica para el tratamiento y la prevencion de nafld. |
| CN115305207B (zh) * | 2022-07-01 | 2024-04-12 | 厦门大学 | 一种全合成培养基、制备方法及其用于三孢布拉氏霉菌的培养方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05292885A (ja) | 1992-04-22 | 1993-11-09 | Asahi Denka Kogyo Kk | チョコレート組成物 |
| DK1997498T3 (da) * | 2001-06-18 | 2012-07-30 | Neptune Technologies & Bioressources Inc | Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme |
| MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
| US20040219188A1 (en) * | 2003-05-02 | 2004-11-04 | Comer Gail M. | Composition and methods for nutritional management of patients with hepatic disease |
| AU2003275419A1 (en) * | 2003-10-03 | 2005-05-19 | Green Meadows Research, Llc A And L Goodbody | Lotus and methyl donors |
| WO2006063219A2 (en) * | 2004-12-09 | 2006-06-15 | Pro-Health, Inc. | Product and method for oral administration of nutraceuticals |
| ES2241503B2 (es) * | 2005-04-19 | 2008-07-01 | Eduardo Sabio Rey | Procedimiento para preparar formulaciones enriquecidas en licopeno libres de disolventes organicos, formulaciones obtenidas, composiciones que comprenden dichas formulaciones y uso de las mismas. |
| AU2011218634B2 (en) | 2005-10-26 | 2013-06-20 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
| JP2010538674A (ja) * | 2007-09-19 | 2010-12-16 | オフサルモファーマ・アクチェンゲゼルシャフト | 栄養補助剤およびそのような補助剤を含む強化食品 |
| JP5950292B2 (ja) | 2008-12-05 | 2016-07-13 | 味の素株式会社 | 栄養組成物 |
| US20100159029A1 (en) | 2008-12-23 | 2010-06-24 | Alcon Research, Ltd. | Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response |
| IT1393710B1 (it) * | 2009-04-29 | 2012-05-08 | Graal Srl | Composizioni orobuccali contenenti una miscela di luteina e zeaxantina. |
| EP2542096B1 (en) * | 2010-03-05 | 2015-07-15 | Ophthalmopharma AG | Nutraceutical chocolate or compound chocolate product |
| US20140205627A1 (en) * | 2010-04-30 | 2014-07-24 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to improve blood lipid profiles and reduce low density lipoprotein (ldl) per-oxidation in humans using algae based oils and astaxanthin |
| CN101816330B (zh) * | 2010-05-31 | 2012-04-18 | 澳优乳业（中国）有限公司 | 一种含β-胡萝卜素的婴幼儿奶粉及其制备方法 |
| GB201101669D0 (en) | 2011-01-31 | 2011-03-16 | Ip Science Ltd | Carotenoid particles and uses thereof |
| US20120252888A1 (en) | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
| GB201120772D0 (en) | 2011-12-02 | 2012-01-11 | Ip Science Ltd | Cocoa-based food products |
| US20140170247A1 (en) * | 2012-09-14 | 2014-06-19 | Guardion Health Sciences, Llc | Emulsion of Carotenoids and Ocular Antioxidants |
| FR2996136B1 (fr) * | 2012-09-28 | 2015-01-02 | Inneov Lab | Utilisation d'une association d'au moins un acide gras polyinsature et d'au moins un carotenoide pour ameliorer la qualite des ongles. |
| US9629820B2 (en) * | 2012-12-24 | 2017-04-25 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
| WO2015073515A1 (en) | 2013-11-12 | 2015-05-21 | Abbott Laboratories | Uses of nutritional compositions including natural vitamin e, and polyunsaturated fatty acid |
-
2017
- 2017-11-03 BR BR112019008739A patent/BR112019008739A2/pt not_active Application Discontinuation
- 2017-11-03 JP JP2019545865A patent/JP2019534329A/ja active Pending
- 2017-11-03 US US16/346,955 patent/US11696920B2/en active Active
- 2017-11-03 CN CN201780082689.9A patent/CN110198706A/zh active Pending
- 2017-11-03 CA CA3042592A patent/CA3042592A1/en active Pending
- 2017-11-03 EP EP17800452.9A patent/EP3534884A1/en active Pending
- 2017-11-03 WO PCT/EP2017/078242 patent/WO2018083271A1/en not_active Ceased
-
2019
- 2019-05-01 IL IL266385A patent/IL266385A/en unknown
-
2023
- 2023-06-09 US US18/207,893 patent/US20230310470A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Punia et al. | Omega 3-metabolism, absorption, bioavailability and health benefits–A review | |
| Hernandez | Specialty oils: functional and nutraceutical properties | |
| Timilsena et al. | Advances in microencapsulation of polyunsaturated fatty acids (PUFAs)-rich plant oils using complex coacervation: A review | |
| Kaur et al. | Essential fatty acids as functional components of foods-a review | |
| Ryckebosch et al. | Stability of omega-3 LC-PUFA-rich photoautotrophic microalgal oils compared to commercially available omega-3 LC-PUFA oils | |
| JP6038641B2 (ja) | 油脂の酸化防止剤 | |
| ES2368315A1 (es) | Nuevo extracto de semilla derivado de planta rico en ácidos grasos esenciales derivados de semilla de salvia hispanica l.: composición de materia, proceso de fabricación y su uso. | |
| ITMI20002854A1 (it) | Preparazioni nutrizionali e terapeutiche dotate di attivita' antiossidante ed in grado di controllare gli eccessi ponderali e l'irrigidiment | |
| WO2008147562A3 (en) | Dietary formulations and methods for treatment of inflammation and other disorders | |
| US20230310470A1 (en) | Intelligent delivery of ingested and absorbed molecules | |
| EP2506848A4 (en) | SUBSTANCES TO REDUCE THE IMPACT OF HARD CARDIAL EVENTS CONTAINING AN EXTRACT OF RED FERMENTED RICE AND A MULTIPLE UNSATURATED OMEGA-3 FATTY ACID OR DERIVATIVES THEREOF | |
| JP2019534329A5 (enExample) | ||
| JPWO2005061684A1 (ja) | 油脂組成物 | |
| WO2006078457A3 (en) | Use of resolvins to treat gastrointestinal diseases | |
| Salsinha et al. | Bioactive lipids: Chemistry, biochemistry, and biological properties | |
| CA3069902A1 (en) | Compositions comprising thymoquinone and omega-3 fatty acids | |
| JP2012514596A (ja) | バイオオイル組成物、上記オイル組成物を含む製剤と、循環器疾患の予防又は治療のためのその使用 | |
| Pagliaro et al. | Sustainably sourced olive polyphenols and omega-3 marine lipids: A synergy fostering public health | |
| Dave et al. | An overview on recent advances in functional properties of dietary lipids, encapsulation strategies and applications | |
| Arumugam et al. | Formulation and storage stability of beta carotene enriched Vitamin D3 and omega 3 fortified cold pressed virgin coconut oil | |
| Nath et al. | Role of Omega-3s in Functional Foods | |
| Akonjuen | Encapsulation of Njangsa Seed Oil and Its Application in Functional Food Development | |
| IL276049B1 (en) | Fat emulsion nutritional product | |
| NZ766737B2 (en) | Protecting a bioactive and/or precursor thereof | |
| MX2022001238A (es) | Composicion lipidica que comprende antioxidantes y polifenoles naturales como alternativa no farmacologica para el tratamiento y la prevencion de nafld. |